Inhaltsbereich
| 117 Einträge | 1, 2, 3, 4, 5, 6 › » |
Seite 1 / 6
 Druckansicht
|
| Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma. |
| Choueiri TK, Escudier B, Powles T, Mainwaring PN, Rini BI, Donskov F, Hammers H, Hutson TE, Lee JL, Peltola K, Roth BJ, Bjarnason GA, Géczi L, Keam B, Maroto P, Heng DY, Schmidinger M, Kantoff PW, Borgman-Hagey A, Hessel C, Scheffold C, Schwab GM, Tannir NM, Motzer RJ |
| The New England journal of medicine. 2015 Sep 25. doi: 10.1056/NEJMoa1510016 |
| PMID: 26406150 |
| External validation of 2 models to predict necrosis/fibrosis in postchemotherapy residual retroperitoneal masses of patients with advanced testicular cancer. |
| Paffenholz P, Nestler T, Hoier S, Pfister D, Hellmich M, Heidenreich A |
| Urologic oncology. 2019 Sep 17. pii: S1078-1439(19)30298-4. doi: 10.1016/j.urolonc.2019.07.021 |
| PMID: 31540832 |
| Underestimation of PET/CT Scan in Assessing Tumour Burden of Men With Nodal Recurrence From Prostate Cancer: Head-to-Head Comparison OF Ga-PSMA and C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections. |
| Fossati N, Scarcella S, Gandaglia G, Suardi N, Robesti D, Boeri L, Karnes RJ, Heidenreich A, Pfister D, Kretschmer A, Buchner A, Stief C, Battaglia A, Joniau S, Van Poppel H, Osmonov D, Juenemann KP, Shariat S, Hiester A, Nini A, Albers P, Tilki D, Graefen M, Gill IS, Mottrie A, Galosi AB, Montorsi F, Briganti A |
| The Journal of urology. 2020 Feb 18. doi: 10.1097/JU.0000000000000800 |
| PMID: 32068488 |
| Pelvic exenteration surgery in patients with locally advanced castration-naïve and castration-resistant, symptomatic prostate cancer. |
| Heidenreich A, Bludau M, Bruns C, Nestler T, Porres D, Pfister DJKP |
| BJU international. 2020 Apr 22. doi: 10.1111/bju.15088 |
| PMID: 32320130 |
| Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. |
| Bravi CA, Fossati N, Gandaglia G, Suardi N, Mazzone E, Robesti D, Osmonov D, Juenemann KP, Boeri L, Jeffrey Karnes R, Kretschmer A, Buchner A, Stief C, Hiester A, Nini A, Albers P, Devos G, Joniau S, Van Poppel H, Shariat SF, Heidenreich A, Pfister D, Tilki D, Graefen M, Gill IS, Mottrie A, Karakiewicz PI, Montorsi F, Briganti A |
| European urology. 2020 Jul 2. pii: S0302-2838(20)30472-3. doi: 10.1016/j.eururo.2020.06.043 |
| PMID: 32624288 |
| Assessing the Best Surgical Template at Salvage Pelvic Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: When Can Bilateral Dissection be Omitted? Results from a Multi-institutional Series. |
| Bravi CA, Fossati N, Gandaglia G, Suardi N, Mazzone E, Robesti D, Osmonov D, Juenemann KP, Boeri L, Jeffrey Karnes R, Kretschmer A, Buchner A, Stief C, Hiester A, Nini A, Albers P, Devos G, Joniau S, Van Poppel H, Shariat SF, Heidenreich A, Pfister D, Tilki D, Graefen M, Gill IS, Mottrie A, Karakiewicz PI, Montorsi F, Briganti A |
| European urology. 2020 Jul 2. pii: S0302-2838(20)30507-8. doi: 10.1016/j.eururo.2020.06.047 |
| PMID: 32624281 |
| [Using preorchiectomy tumor marker serum concentrations for International Germ Cell Consensus Classification (IGCCCG) risk group assignment results in significant numbers of up- and downstaging]. |
| Paffenholz P, Nestler T, Maatoug Y, von Brandenstein M, Köditz B, Pfister D, Heidenreich A |
| Der Urologe. Ausg. A. 2021 Jan 11. doi: 10.1007/s00120-020-01432-1. pii: 10.1007/s00120-020-01432-1 |
| PMID: 33427889 |
| Salvage management of patients with relapsing testicular germ cell tumors. |
| Heidenreich A, Pfister D, Paffenholz P |
| Current opinion in urology. 2021 Mar 17. doi: 10.1097/MOU.0000000000000875. pii: 00042307-900000000-98889 |
| PMID: 33742980 |
| NASH limits anti-tumour surveillance in immunotherapy-treated HCC. |
| Pfister D, Núñez NG, Pinyol R, Govaere O, Pinter M, Szydlowska M, Gupta R, Qiu M, Deczkowska A, Weiner A, Müller F, Sinha A, Friebel E, Engleitner T, Lenggenhager D, Moncsek A, Heide D, Stirm K, Kosla J, Kotsiliti E, Leone V, Dudek M, Yousuf S, Inverso D, Singh I, Teijeiro A, Castet F, Montironi C, Haber PK, Tiniakos D, Bedossa P, Cockell S, Younes R, Vacca M, Marra F, Schattenberg JM, Allison M, Bugianesi E, Ratziu V, Pressiani T, D'Alessio A, Personeni N, Rimassa L, Daly AK, Scheiner B, Pomej K, Kirstein MM, Vogel A, Peck-Radosavljevic M, Hucke F, Finkelmeier F, Waidmann O, Trojan J, Schulze K, Wege H, Koch S, Weinmann A, Bueter M, Rössler F, Siebenhüner A, Dosso S, Mallm JP, Umansky V, Jugold M, Luedde T, Schietinger A, Schirmacher P, Emu B, Augustin HG, Billeter A, Müller-Stich B, Kikuchi H, Duda DG, Kütting F, Waldschmidt DT, Ebert MP, Rahbari N, Mei HE, Schulz AR, Ringelhan M, Malek N, Spahn S, Bitzer M, Ruiz de Galarreta M, Lujambio A, Dufour JF, Marron TU, Kaseb A, Kudo M, Huang YH, Djouder N, Wolter K, Zender L, Marche PN, Decaens T, Pinato DJ, Rad R, Mertens JC, Weber A, Unger K, Meissner F, Roth S, Jilkova ZM, Claassen M, Anstee QM, Amit I, Knolle P, Becher B, Llovet JM, Heikenwalder M |
| Nature. 2021 Mar 24. doi: 10.1038/s41586-021-03362-0. pii: 10.1038/s41586-021-03362-0 |
| PMID: 33762733 |
| Teratomatous Elements in Orchiectomy Specimens Are Associated with a Reduced Relapse-Free Survival in Metastasized Testicular Germ Cell Tumors. |
| Paffenholz P, Nestler T, Maatoug Y, von Brandenstein M, Köditz B, Loosen SH, Fischer N, Pfister D, Heidenreich A |
| Urologia internationalis. 2021 Jun 15. pii: 000515715. doi: 10.1159/000515715 |
| PMID: 34130302 |
| Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy. |
| Bravi CA, Droghetti M, Fossati N, Gandaglia G, Suardi N, Mazzone E, Cucchiara V, Scuderi S, Barletta F, Schiavina R, Osmonov D, Juenemann KP, Boeri L, Karnes RJ, Kretschmer A, Buchner A, Stief C, Hiester A, Nini A, Albers P, Devos G, Joniau S, Van Poppel H, Grubmüller B, Shariat SF, Heidenreich A, Pfister D, Tilki D, Graefen M, Gill IS, Mottrie A, Karakiewicz PI, Montorsi F, Briganti A |
| European urology oncology. 2021 Jun 24. pii: S2588-9311(21)00118-8. doi: 10.1016/j.euo.2021.06.003 |
| PMID: 34176768 |
| Transcriptome analysis reveals upregulation of immune response pathways at the invasive tumour front of metastatic seminoma germ cell tumours. |
| Nestler T, Dalvi P, Haidl F, Wittersheim M, von Brandenstein M, Paffenholz P, Wagener-Ryczek S, Pfister D, Koitzsch U, Hellmich M, Buettner R, Odenthal M, Heidenreich A |
| British journal of cancer. 2022 Jan 12. doi: 10.1038/s41416-021-01621-5. pii: 10.1038/s41416-021-01621-5 |
| PMID: 35022523 |
| Differentially expressed messenger RNA/proteins can distinguish teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection (pcRPLND) tissue. |
| Nestler T, Kremer L, von Brandenstein M, Wittersheim M, Paffenholz P, Wagener-Ryczek S, Quaas A, Hellmich M, Müller S, Pfister D, Odenthal M, Heidenreich A |
| Cancer. 2022 Dec 11. doi: 10.1002/cncr.34571 |
| PMID: 36504384 |
| Importance of magnetic resonance imaging and prostate-specific membrane antigen PET-CT in patients treated with salvage radical prostatectomy for radiorecurrent prostate cancer. |
| Rajwa P, Pfister D, Rieger C, Heidenreich J, Drzezga A, Persigehl T, Shariat SF, Heidenreich A |
| The Prostate. 2022 Dec 23. doi: 10.1002/pros.24470 |
| PMID: 36564936 |
| Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer. |
| Bravi CA, Heidenreich A, Fossati N, Gandaglia G, Suardi N, Mazzone E, Stabile A, Cucchiara V, Osmonov D, Juenemann KP, Karnes RJ, Kretschmer A, Buchner A, Stief C, Hiester A, Albers P, Devos G, Joniau S, Van Poppel H, Grubmüller B, Shariat S, Tilki D, Graefen M, Gill IS, Mottrie A, Karakiewicz PI, Montorsi F, Briganti A, Pfister D |
| BJUI compass. 2022 Aug 4. pmc: PMC9766859. doi: 10.1002/bco2.182. pii: BCO2182 |
| PMID: 36569505 |
| Rucaparib or Physician's Choice in Metastatic Prostate Cancer. |
| Fizazi K, Piulats JM, Reaume MN, Ostler P, McDermott R, Gingerich JR, Pintus E, Sridhar SS, Bambury RM, Emmenegger U, Lindberg H, Morris D, Nolè F, Staffurth J, Redfern C, Sáez MI, Abida W, Daugaard G, Heidenreich A, Krieger L, Sautois B, Loehr A, Despain D, Heyes CA, Watkins SP, Chowdhury S, Ryan CJ, Bryce AH |
| The New England journal of medicine. 2023 Feb 16. doi: 10.1056/NEJMoa2214676 |
| PMID: 36795891 |
| German specialists treating testicular cancer follow different guidelines with resulting inconsistency in assessment of retroperitoneal lymph-node metastasis: clinical implications and possible corrective measures. |
| Schoch J, Haunschild K, Strauch A, Nestler K, Schmelz H, Paffenholz P, Pfister D, Persigehl T, Heidenreich A, Nestler T |
| World journal of urology. 2023 Apr 4. doi: 10.1007/s00345-023-04364-5. pii: 10.1007/s00345-023-04364-5 |
| PMID: 37014392 |
| Retroperitoneal Lymph Node Dissection in Clinical Stage IIA/B Metastatic Seminoma: Results of the COlogne Trial of Retroperitoneal Lymphadenectomy In Metastatic Seminoma (COTRIMS). |
| Heidenreich A, Paffenholz P, Hartmann F, Seelemeyer F, Pfister D |
| European urology oncology. 2023 Jul 10. doi: 10.1016/j.euo.2023.06.004. pii: S2588-9311(23)00117-7 |
| PMID: 37438222 |
| IL28B polymorphism cannot predict response to interferon alpha treatment in patients with melanoma. |
| Probst M, Hoeller C, Ferenci P, Staettermayer AF, Beinhardt S, Pehamberger H, Kittler H, Grabmeier-Pfistershammer K |
| PloS one. 2014 Nov 12. doi: 10.1371/journal.pone.0112613. pii: PONE-D-14-33575. pmc: PMC4229256 |
| PMID: 25389973 |
| The effect of gender and age on kidney cancer survival: younger age is an independent prognostic factor in women with renal cell carcinoma. |
| Rampersaud EN, Klatte T, Bass G, Patard JJ, Bensaleh K, Böhm M, Allhoff EP, Cindolo L, De La Taille A, Mejean A, Soulie M, Bellec L, Christophe Bernhard J, Pfister C, Colombel M, Belldegrun AS, Pantuck AJ, George D |
| Urologic oncology. 2013 Feb 17. pii: S1078-1439(12)00358-4. doi: 10.1016/j.urolonc.2012.10.012 |
| PMID: 23422777 |
| 117 Einträge | 1, 2, 3, 4, 5, 6 › » |
Seite 1 / 6
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
